triazolam has been researched along with Alcoholism in 7 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Alcoholism: A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insomnia and anxiety decreased in 12 outpatients taking triazolam following alcohol withdrawal." | 3.65 | Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal. ( Fabre, LF; Gainey, A; Kemple, S; McLendon, DM; Metzler, CM, 1977) |
| " The maximal dosage was 8 capsules per day (2." | 2.65 | Studies on the dependence-inducing potential of zopiclone and triazolam. ( Boissl, K; Delmotte, M; Dreyfus, JF, 1982) |
| " We report five cases of high-dose triazolam abuse in which the daily dosage ranged from 5 to 15 mg (100-300 mg diazepam equivalent) and the duration of use ranged from 3 months to 5 years." | 1.28 | Detoxification for triazolam physical dependence. ( Sellers, EM; Sullivan, JT, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, JA | 1 |
| Bechelli, LP | 2 |
| Navas, F | 2 |
| Pierangelo, SA | 2 |
| Boissl, K | 1 |
| Dreyfus, JF | 1 |
| Delmotte, M | 1 |
| Weingartner, HJ | 1 |
| Rawlings, R | 1 |
| George, DT | 1 |
| Eckardt, M | 1 |
| Fabre, LF | 1 |
| Gainey, A | 1 |
| Kemple, S | 1 |
| McLendon, DM | 1 |
| Metzler, CM | 1 |
| Sullivan, JT | 1 |
| Sellers, EM | 1 |
2 trials available for triazolam and Alcoholism
| Article | Year |
|---|---|
Studies on the dependence-inducing potential of zopiclone and triazolam.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Azabicyclo Compounds; Double-Blind Method; Humans; Hypnotics | 1982 |
Triazolam-induced changes in alcoholic thought processes.
Topics: Adult; Alcoholism; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Female; Humans; Hy | 1998 |
5 other studies available for triazolam and Alcoholism
| Article | Year |
|---|---|
Triazolam abuse.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Humans; Male; Sleep Initiation and Maintenance Disorders; Su | 1983 |
Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Azabicyclo Compounds; Double-B | 1983 |
Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Azabicyclo Compounds; Capsules; Double-Blind Method; Electro | 1982 |
Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Drug Evaluation; Female; Humans; Male; Middle Aged; | 1977 |
Detoxification for triazolam physical dependence.
Topics: Adult; Alcoholism; Diazepam; Dose-Response Relationship, Drug; Female; Half-Life; Hospitalization; H | 1992 |